Glaukos Operating Expenses 2014-2025 | GKOS
Glaukos annual/quarterly operating expenses history and growth rate from 2014 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Glaukos operating expenses for the quarter ending June 30, 2025 were $0.147B, a 16.83% increase year-over-year.
- Glaukos operating expenses for the twelve months ending June 30, 2025 were $0.530B, a 10.94% increase year-over-year.
- Glaukos annual operating expenses for 2024 were $0.506B, a 14.08% increase from 2023.
- Glaukos annual operating expenses for 2023 were $0.443B, a 21.42% increase from 2022.
- Glaukos annual operating expenses for 2022 were $0.365B, a 11.71% increase from 2021.
| Glaukos Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $506 |
| 2023 | $443 |
| 2022 | $365 |
| 2021 | $327 |
| 2020 | $349 |
| 2019 | $287 |
| 2018 | $194 |
| 2017 | $162 |
| 2016 | $110 |
| 2015 | $82 |
| 2014 | $59 |
| 2013 | $35 |
| Glaukos Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-06-30 | $147 |
| 2025-03-31 | $127 |
| 2024-12-31 | $134 |
| 2024-09-30 | $121 |
| 2024-06-30 | $126 |
| 2024-03-31 | $125 |
| 2023-12-31 | $121 |
| 2023-09-30 | $106 |
| 2023-06-30 | $109 |
| 2023-03-31 | $107 |
| 2022-12-31 | $105 |
| 2022-09-30 | $93 |
| 2022-06-30 | $109 |
| 2022-03-31 | $58 |
| 2021-12-31 | $91 |
| 2021-09-30 | $64 |
| 2021-06-30 | $92 |
| 2021-03-31 | $80 |
| 2020-12-31 | $85 |
| 2020-09-30 | $77 |
| 2020-06-30 | $79 |
| 2020-03-31 | $108 |
| 2019-12-31 | $96 |
| 2019-09-30 | $71 |
| 2019-06-30 | $65 |
| 2019-03-31 | $56 |
| 2018-12-31 | $52 |
| 2018-09-30 | $51 |
| 2018-06-30 | $47 |
| 2018-03-31 | $44 |
| 2017-12-31 | $41 |
| 2017-09-30 | $40 |
| 2017-06-30 | $45 |
| 2017-03-31 | $36 |
| 2016-12-31 | $33 |
| 2016-09-30 | $29 |
| 2016-06-30 | $26 |
| 2016-03-31 | $22 |
| 2015-12-31 | $22 |
| 2015-09-30 | $21 |
| 2015-06-30 | $23 |
| 2015-03-31 | $16 |
| 2014-12-31 | $19 |
| 2014-09-30 | $14 |
| 2014-06-30 | $13 |
| 2014-03-31 | $12 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.124B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.276B | 21.81 |
| Intuitive Surgical (ISRG) | United States | $171.420B | 71.05 |
| IDEXX Laboratories (IDXX) | United States | $52.185B | 54.31 |
| Edwards Lifesciences (EW) | United States | $45.166B | 29.93 |
| Alcon (ALC) | Switzerland | $42.434B | 28.68 |
| IQVIA Holdings (IQV) | United States | $31.605B | 17.86 |
| DexCom (DXCM) | United States | $31.439B | 47.16 |
| Mettler-Toledo (MTD) | United States | $26.632B | 31.61 |
| STERIS (STE) | Ireland | $24.008B | 25.55 |
| Waters (WAT) | United States | $16.995B | 23.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.710B | 0.00 |
| Hologic (HOLX) | United States | $15.113B | 16.37 |
| Penumbra (PEN) | United States | $9.693B | 70.81 |
| Sysmex ADR (SSMXY) | Japan | $8.813B | 28.00 |
| Globus Medical (GMED) | United States | $8.376B | 19.27 |
| Masimo (MASI) | United States | $8.156B | 27.45 |
| Teleflex (TFX) | United States | $5.287B | 8.53 |
| TransMedics (TMDX) | United States | $4.470B | 67.94 |
| Integer Holdings (ITGR) | United States | $3.760B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.765B | 15.82 |
| Alphatec Holdings (ATEC) | United States | $2.326B | 0.00 |
| Veracyte (VCYT) | United States | $2.263B | 31.27 |
| PROCEPT BioRobotics (PRCT) | United States | $2.148B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.073B | 24.75 |
| Artivion (AORT) | United States | $2.069B | 104.40 |
| Elekta AB (EKTAY) | Sweden | $1.879B | 16.90 |
| Integra LifeSciences Holdings (IART) | United States | $1.073B | 6.15 |
| OPKO Health (OPK) | United States | $1.048B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.06 |
| Tandem Diabetes Care (TNDM) | United States | $0.750B | 0.00 |
| SiBone (SIBN) | United States | $0.656B | 0.00 |
| AxoGen (AXGN) | United States | $0.652B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.618B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.511B | 4.11 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.501B | 8.84 |
| OrthoPediatrics (KIDS) | United States | $0.492B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.413B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.348B | 8.85 |
| RxSight (RXST) | United States | $0.301B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.34 |
| Alpha Tau Medical (DRTS) | Israel | $0.276B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.114B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| DarioHealth (DRIO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.80 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |